Cited by 430CRISPR and Genetic EngineeringRNA Interference and Gene DeliveryNanoparticle-Based Drug Delivery

Strategies in the delivery of Cas9 ribonucleoprotein for CRISPR/Cas9 genome editing

Open access
Zhang, Song, Shen, Jiangtao, Li, Dali, Cheng, Yiyun·2021·Theranostics

Abstract

CRISPR/Cas9 genome editing has gained rapidly increasing attentions in recent years, however, the translation of this biotechnology into therapy has been hindered by efficient delivery of CRISPR/Cas9 materials into target cells. Direct delivery of CRISPR/Cas9 system as a ribonucleoprotein (RNP) complex consisting of Cas9 protein and single guide RNA (sgRNA) has emerged as a powerful and widespread method for genome editing due to its advantages of transient genome editing and reduced off-target effects. In this review, we summarized the current Cas9 RNP delivery systems including physical approaches and synthetic carriers. The mechanisms and beneficial roles of these strategies in intracellular Cas9 RNP delivery were reviewed. Examples in the development of stimuli-responsive and targeted carriers for RNP delivery are highlighted. Finally, the challenges of current Cas9 RNP delivery systems and perspectives in rational design of next generation materials for this promising field will be discussed.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.7150/thno.47007

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • RNP methods show a 2.5- to 28-fold reduction in off-target effects compared to plasmid-based methods.

    “More specifically, a 2.5- to 28-fold reduction in off-target effects has been reported with an RNP method compared to plasmid-based methods (Liang et al., 2015; Zhang et al., 2021).”

    From Efficient genetic editing of human intestinal organoids using ribonucleoprotein-based CRISPR (2023) · cites this paper as Zhang et al., 2021

    The Conclusions and perspectives section says direct RNP delivery has lower off-target effects than Cas9 plasmid delivery. It does not report the claimed 2.5- to 28-fold reduction, so the quantitative part is unsupported by this source. (LLM, conf=0.87)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 254

  1. [1]Doudna JA Charpentier E The new frontier of genome engineering with CRISPR-Cas9 Science 2014 346 1258096 25430774
  2. [2]Wilson RC Gilbert LA The promise and challenge of in vivo delivery for genome therapeutics ACS Chem Biol 2018 13 376 82 29019396 PMC5906052
  3. [3]Cox DBT Platt RJ Zhang F Therapeutic genome editing: prospects and challenges Nat Med 2015 21 121 31 25654603 PMC4492683
  4. [4]Eid A Mahfouz MM Genome editing: the road of CRISPR/Cas9 from bench to clinic Exp Mol Med 2016 48 e265 27741224 PMC5099421
  5. [5]Staahl BT Benekareddy M Coulon-Bainier C Banfal AA Floor SN Sabo JK Efficient genome editing in the mouse brain by local delivery of engineered Cas9 ribonucleoprotein complexes Nat Biotechnol 2017 35 431 4 28191903 PMC6649674
  6. [6]Mintzer MA Simanek EE Nonviral vectors for gene delivery Chem Rev 2009 109 259 302 19053809
  7. [7]Hussain W Mahmood T Hussain J Ali N Shah T Qayyum S CRISPR/Cas system: A game changing genome editing technology, to treat human genetic diseases Gene 2019 685 70 5 30393194
  8. [8]Khadempar S Familghadakchi S Motlagh RA Farahani N Dashtiahangar M Rezaei H CRISPR-Cas9 in genome editing: Its function and medical applications J Cell Physiol 2019 234 5751 61 30362544
  9. [9]Ishino Y Shinagawa H Makino K Amemura M Nakata A Nucleotide sequence of the iap gene, responsible for alkaline phosphatase isozyme conversion in Escherichia coli, and identification of the gene product J Bacteriol 1987 169 5429 33 3316184 PMC213968
  10. [10]Jansen R Embden JDAv Gaastra W Schouls LM Identification of genes that are associated with DNA repeats in prokaryotes Mol Microbiol 2002 43 1565 75 11952905
  11. [11]Mojica FJM Díez-Villaseñor Cs García-Martínez J Soria E Intervening sequences of regularly spaced prokaryotic repeats derive from foreign genetic elements J Mol Evol 2005 60 174 82 15791728
  12. [12]Bolotin A Quinquis B Sorokin A Ehrlich SD Clustered regularly interspaced short palindrome repeats (CRISPRs) have spacers of extrachromosomal origin Microbiology 2005 151 2551 61 16079334
  13. [13]Barrangou R Fremaux C Deveau H Richards M Boyaval P Moineau S CRISPR provides acquired resistance against viruses in prokaryotes Science 2007 315 1709 17379808
  14. [16]Mali P Yang L Esvelt KM Aach J Guell M DiCarlo JE RNA-guided human genome engineering via Cas9 Science 2013 339 823 6 23287722 PMC3712628
  15. [19]Niu Y Shen B Cui Y Chen Y Wang J Wang L Generation of gene-modified cynomolgus monkey via Cas9/RNA-mediated gene targeting in one-cell embryos Cell 2014 156 836 43 24486104
  16. [20]Bassett AR Liu JL CRISPR/Cas9 and genome editing in Drosophila J Genet Genomics 2014 41 7 19 24480743
  17. [21]Oh JH van Pijkeren JP CRISPR-Cas9-assisted recombineering in Lactobacillus reuteri Nucleic Acids Res 2014 42 e131 25074379 PMC4176153
  18. [22]Belhaj K Chaparro-Garcia A Kamoun S Patron NJ Nekrasov V Editing plant genomes with CRISPR/Cas9 Curr Opin Biotechnol 2015 32 76 84 25437637
  19. [23]Li JF Zhang D Sheen J Cas9-based genome editing in Arabidopsis and tobacco Methods Enzymol 2014 546 459 72 25398353
  20. [24]Li D Qiu Z Shao Y Chen Y Guan Y Liu M Heritable gene targeting in the mouse and rat using a CRISPR-Cas system Nat Biotechnol 2013 31 681 3 23929336
  21. [25]Makarova KS Wolf YI Alkhnbashi OS Costa F Shah SA Saunders SJ An updated evolutionary classification of CRISPR-Cas systems Nat Rev Microbiol 2015 13 722 36 26411297 PMC5426118
  22. [26]Mashimo T Gene targeting technologies in rats: Zinc finger nucleases, transcription activator-like effector nucleases, and clustered regularly interspaced short palindromic repeats Dev, Growth Differ 2014 56 46 52 24372523
  23. [28]Liu C Zhang L Liu H Cheng K Delivery strategies of the CRISPR-Cas9 gene-editing system for therapeutic applications J Controlled Release 2017 266 17 26 PMC5723556 28911805
  24. [29]van der Oost J Westra ER Jackson RN Wiedenheft B Unravelling the structural and mechanistic basis of CRISPR-Cas systems Nat Rev Microbiol 2014 12 479 92 24909109 PMC4225775
  25. [30]Garneau JE Dupuis M Villion M Romero DA Barrangou R Boyaval P The CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA Nature 2010 468 67 71 21048762
  26. [31]Jinek M Chylinski K Fonfara I Hauer M Doudna JA Charpentier E A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity Science 2012 337 816 21 22745249 PMC6286148
  27. [32]Jinek M Jiang F Taylor DW Sternberg SH Kaya E Ma E Structures of Cas9 endonucleases reveal RNA-mediated conformational activation Science 2014 343 1247997 24505130 PMC4184034
  28. [34]Moehle EA Rock JM Lee Y-L Jouvenot Y DeKelver RC Gregory PD Targeted gene addition into a specified location in the human genome using designed zinc finger nucleases Proc Natl Acad Sci U S A 2007 104 3055 60 17360608 PMC1802009
  29. [36]Wilson JH Berget PB Pipas JM Somatic cells efficiently join unrelated DNA segments end-to-end Mol Cell Biol 1982 2 1258 69 6294502 PMC369925
  30. [37]Roth DB Wilson JH Relative rates of homologous and nonhomologous recombination in transfected DNA Proc Natl Acad Sci U S A 1985 82 3355 9 2987922 PMC397774
  31. [38]Capecchi MR Altering the genome by homologous recombination Science 1989 244 1288 2660260
  32. [39]Jensen RB Rothenberg E Preserving genome integrity in human cells via DNA double-strand break repair Mol Biol Cell 2020 31 859 65 32286930 PMC7185975
  33. [40]Thomas KR Folger KR Capecchi MR High frequency targeting of genes to specific sites in the mammalian genome Cell 1986 44 419 28 3002636
  34. [41]Smithies O Gregg RG Boggs SS Koralewski MA Kucherlapati RS Insertion of DNA sequences into the human chromosomal β-globin locus by homologous recombination Nature 1985 317 230 4 2995814
  35. [42]Suzuki K Izpisua Belmonte JC In vivo genome editing via the HITI method as a tool for gene therapy J Hum Genet 2018 63 157 64 29215090
  36. [43]Cui Z Jiang X Zheng H Qi Q Hou J Homology-independent genome integration enables rapid library construction for enzyme expression and pathway optimization in Yarrowia lipolytica Biotechnol Bioeng 2019 116 354 63 30418662
  37. [44]Gao D Smith S Spagnuolo M Rodriguez G Blenner M Dual CRISPR-Cas9 cleavage mediated gene excision and targeted integration in Yarrowia lipolytica Biotechnol J 2018 13 e1700590 29809313
  38. [45]Seol JH Shim EY Lee SE Microhomology-mediated end joining: Good, bad and ugly Mutat Res 2018 809 81 7 28754468 PMC6477918
  39. [46]van Schendel R van Heteren J Welten R Tijsterman M Genomic scars generated by polymerase theta reveal the versatile mechanism of alternative end-joining PLoS Genet 2016 12 e1006368 27755535 PMC5068794
  40. [47]Li L Liu X Wei K Lu Y Jiang W Synthetic biology approaches for chromosomal integration of genes and pathways in industrial microbial systems Biotechnol Adv 2019 37 730 45 30951810
  41. [48]Nakade S Tsubota T Sakane Y Kume S Sakamoto N Obara M Microhomology-mediated end-joining-dependent integration of donor DNA in cells and animals using TALENs and CRISPR/Cas9 Nat Commun 2014 5 5560 25410609 PMC4263139
  42. [49]Auer TO Duroure K De Cian A Concordet JP Del Bene F Highly efficient CRISPR/Cas9-mediated knock-in in zebrafish by homology-independent DNA repair Genome Res 2014 24 142 53 24179142 PMC3875856
  43. [50]Hisano Y Sakuma T Nakade S Ohga R Ota S Okamoto H Precise in-frame integration of exogenous DNA mediated by CRISPR/Cas9 system in zebrafish Sci Rep 2015 5 8841 25740433 PMC4350073
  44. [51]Suzuki K Tsunekawa Y Hernandez-Benitez R Wu J Zhu J Kim EJ In vivo genome editing via CRISPR/Cas9 mediated homology-independent targeted integration Nature 2016 540 144 9 27851729 PMC5331785
  45. [52]Yao X Wang X Hu X Liu Z Liu J Zhou H Homology-mediated end joining-based targeted integration using CRISPR/Cas9 Cell Res 2017 27 801 14 28524166 PMC5518881
  46. [53]Yao X Wang X Liu J Shi L Huang P Yang H CRISPR/Cas9-mediated targeted integration in vivo using a homology-mediated end joining-based strategy J Vis Exp. 2018: 56844 PMC5931719 29578506
  47. [54]Xie L Sun J Mo L Xu T Shahzad Q Chen D HMEJ-mediated efficient site-specific gene integration in chicken cells J Biol Eng 2019 13 90 31832093 PMC6868705
  48. [55]Wang M Glass ZA Xu Q Non-viral delivery of genome-editing nucleases for gene therapy Gene Ther 2017 24 144 50 27797355
  49. [56]Zuris JA Thompson DB Shu Y Guilinger JP Bessen JL Hu JH Cationic lipid-mediated delivery of proteins enables efficient protein-based genome editing in vitro and in vivo Nat Biotechnol 2015 33 73 80 25357182 PMC4289409
  50. [57]Liu C Wan T Wang H Zhang S Ping Y Cheng Y A boronic acid-rich dendrimer with robust and unprecedented efficiency for cytosolic protein delivery and CRISPR-Cas9 gene editing Sci Adv 2019 5 eaaw8922 31206027 PMC6561739
  51. [58]Guan X Luo Z Sun W A peptide delivery system sneaks CRISPR into cells J Biol Chem 2018 293 17306 7 30389791 PMC6222116
  52. [60]Lattanzi A Meneghini V Pavani G Amor F Ramadier S Felix T Optimization of CRISPR/Cas9 delivery to human hematopoietic stem and progenitor cells for therapeutic genomic rearrangements Mol Ther 2019 27 137 50 30424953 PMC6318785
  53. [61]Chandrasekaran AP Song M Kim KS Ramakrishna S Different methods of delivering CRISPR/Cas9 into cells Prog Mol Biol Transl Sci 2018 159 157 76 30340786
  54. [62]D'Astolfo DS Pagliero RJ Pras A Karthaus WR Clevers H Prasad V Efficient intracellular delivery of native proteins Cell 2015 161 674 90 25910214
  55. [63]Chiper M Niederreither K Zuber G Transduction methods for cytosolic delivery of proteins and bioconjugates into living cells Adv Healthc Mater 2018 7 1701040 29205903
  56. [65]Lv J He B Yu J Wang Y Wang C Zhang S Fluoropolymers for intracellular and in vivo protein delivery Biomaterials 2018 182 167 75 30121426
  57. [66]Qin X Yu C Wei J Li L Zhang C Wu Q Rational design of nanocarriers for intracellular protein delivery Adv Mater 2019 31 1902791 31496027
  58. [67]Stewart MP Langer R Jensen KF Intracellular delivery by membrane disruption: Mechanisms, strategies, and concepts Chem Rev 2018 118 7409 531 30052023 PMC6763210
  59. [68]Lee YW Luther DC Kretzmann JA Burden A Jeon T Zhai S Protein delivery into the cell cytosol using non-viral nanocarriers Theranostics 2019 9 3280 92 31244954 PMC6567963
  60. [69]Geng WC Huang Q Xu Z Wang R Guo DS Gene delivery based on macrocyclic amphiphiles Theranostics 2019 9 3094 106 31244943 PMC6567961
  61. [70]Yin H Kanasty RL Eltoukhy AA Vegas AJ Dorkin JR Anderson DG Non-viral vectors for gene-based therapy Nat Rev Genet 2014 15 541 55 25022906
  62. [71]Wang HX Li M Lee CM Chakraborty S Kim HW Bao G CRISPR/Cas9-based genome editing for disease modeling and therapy: Challenges and opportunities for nonviral delivery Chem Rev 2017 117 9874 906 28640612
  63. [72]Gagnon JA Valen E Thyme SB Huang P Ahkmetova L Pauli A Efficient Mutagenesis by Cas9 Protein-Mediated Oligonucleotide Insertion and Large-Scale Assessment of Single-Guide RNAs PLoS One 2014 9 e98186 24873830 PMC4038517
  64. [73]Kotani H Taimatsu K Ohga R Ota S Kawahara A Efficient Multiple Genome Modifications Induced by the crRNAs, tracrRNA and Cas9 Protein Complex in Zebrafish PLoS One 2015 10 e0128319 26010089 PMC4444095
  65. [74]Liu P Luk K Shin M Idrizi F Kwok S Roscoe B Enhanced Cas12a editing in mammalian cells and zebrafish Nucleic Acids Res 2019 47 4169 80 30892626 PMC6486634
  66. [75]Kim K Ryu SM Kim ST Baek G Kim D Lim K Highly efficient RNA-guided base editing in mouse embryos Nat Biotechnol 2017 35 435 7 28244995
  67. [76]Song Y Xu Y Liang M Zhang Y Chen M Deng J CRISPR/Cas9-mediated mosaic mutation of SRY gene induces hermaphroditism in rabbits Biosci Rep 2018 38 BSR20171490 29439141 PMC5861328
  68. [77]Fei J-F Schuez M Knapp D Taniguchi Y Drechsel DN Tanaka EM Efficient gene knockin in axolotl and its use to test the role of satellite cells in limb regeneration Proc Natl Acad Sci U S A 2017 114 12501 6 29087939 PMC5703281
  69. [78]Cleves PA Strader ME Bay LK Pringle JR Matz MV CRISPR/Cas9-mediated genome editing in a reef-building coral Proc Natl Acad Sci U S A 2018 115 5235 40 29695630 PMC5960312
  70. [79]Dermauw W Jonckheere W Riga M Livadaras I Vontas J Van Leeuwen T Targeted mutagenesis using CRISPR-Cas9 in the chelicerate herbivore Tetranychus urticae Insect Biochem Mol Biol 2020 120 103347 32114158
  71. [80]Meccariello A Tsoumani KT Gravina A Primo P Buonanno M Mathiopoulos KD Targeted somatic mutagenesis through CRISPR/Cas9 ribonucleoprotein complexes in the olive fruit fly, Bactrocera oleae Arch Insect Biochem Physiol 2020 104 e21667 32100335
  72. [81]Chaverra-Rodriguez D Macias VM Hughes GL Pujhari S Suzuki Y Peterson DR Targeted delivery of CRISPR-Cas9 ribonucleoprotein into arthropod ovaries for heritable germline gene editing Nat Commun 2018 9 3008 30068905 PMC6070532
  73. [82]Macias VM McKeand S Chaverra-Rodriguez D Hughes GL Fazekas A Pujhari S Cas9-mediated gene-editing in the malaria mosquito Anopheles stephensi by ReMOT Control G3 (Bethesda) 2020 10 1353 60 32122959 PMC7144067
  74. [83]Heu CC McCullough FM Luan JB Rasgon JL CRISPR-Cas9-based genome editing in the silverleaf whitefly (Bemisia tabaci) Crispr Journal 2020 3 89 96 PMC7194319 32315225
  75. [84]Svitashev S Schwartz C Lenderts B Young JK Mark Cigan A Genome editing in maize directed by CRISPR-Cas9 ribonucleoprotein complexes Nat Commun 2016 7 13274 27848933 PMC5116081
  76. [85]Liang Z Chen K Li T Zhang Y Wang Y Zhao Q Efficient DNA-free genome editing of bread wheat using CRISPR/Cas9 ribonucleoprotein complexes Nat Commun 2017 8 14261 28098143 PMC5253684
  77. [86]Liang Z Chen K Gao C Biolistic delivery of CRISPR/Cas9 with ribonucleoprotein complex in wheat Methods Mol Biol 2019 1917 327 35 30610647
  78. [87]Banakar R Eggenberger AL Lee K Wright DA Murugan K Zarecor S High-frequency random DNA insertions upon co-delivery of CRISPR-Cas9 ribonucleoprotein and selectable marker plasmid in rice Sci Rep 2019 9 19902 31882637 PMC6934568
  79. [88]Serif M Dubois G Finoux AL Teste MA Jallet D Daboussi F One-step generation of multiple gene knock-outs in the diatom Phaeodactylum tricornutum by DNA-free genome editing Nat Commun 2018 9 3924 30254261 PMC6156588
  80. [89]Makhotenko AV Khromov AV Snigir EA Makarova SS Makarov VV Suprunova TP Functional analysis of coilin in virus resistance and stress tolerance of potato solanum tuberosum using CRISPR-Cas9 editing Dokl Biochem Biophys 2019 484 88 91 31012023
  81. [90]Wang P Two distinct approaches for CRISPR-Cas9-mediated gene editing in cryptococcus neoformans and related species Msphere 2018 3 e00208 18 29898980 PMC6001613
  82. [91]Chang KS Kim J Park H Hong S-J Lee C-G Jin E Enhanced lipid productivity in AGP knockout marine microalga Tetraselmis sp. using a DNA-free CRISPR-Cas9 RNP method Bioresour Technol 2020 303 122932 32058903
  83. [92]Boukany PE Morss A Liao WC Henslee B Jung H Zhang X Nanochannel electroporation delivers precise amounts of biomolecules into living cells Nat Nanotechnol 2011 6 747 54 22002097
  84. [93]Modarai SR Man D Bialk P Rivera-Torres N Bloh K Kmiec EB Efficient delivery and nuclear uptake is not sufficient to detect gene editing in CD34+ cells directed by a ribonucleoprotein complex Mol Ther - Nucleic Acids 2018 11 116 29 29858048 PMC5992347
  85. [94]Hendel A Bak RO Clark JT Kennedy AB Ryan DE Roy S Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary cells Nat Biotechnol 2015 33 985 9 26121415 PMC4729442
  86. [96]Wang L Li L Ma Y Hu H Li Q Yang Y Reactivation of γ-globin expression through Cas9 or base editor to treat β-hemoglobinopathies Cell Research 2020 30 276 8 31911671 PMC7054297
  87. [97]Wu Y Zeng J Roscoe BP Liu P Yao Q Lazzarotto CR Highly efficient therapeutic gene editing of human hematopoietic stem cells Nat Med 2019 25 776 83 30911135 PMC6512986
  88. [99]Ihry RJ Worringer KA Salick MR Frias E Ho D Theriault K p53 inhibits CRISPR-Cas9 engineering in human pluripotent stem cells Nat Med 2018 24 939 46 29892062
  89. [101]Lin S Staahl BT Alla RK Doudna JA Enhanced homology-directed human genome engineering by controlled timing of CRISPR/Cas9 delivery eLife 2014 3 e04766 25497837 PMC4383097
  90. [102]Ma L Jang L Chen J Song J Yang D Zhang J CRISPR/Cas9 ribonucleoprotein-mediated precise gene editing by tube electroporation J Vis Exp. 2019: e59512 PMC10095927 31282887
  91. [103]Hung KL Meitlis I Hale M Chen C-Y Singh S Jackson SW Engineering protein-secreting plasma cells by homology-directed repair in primary human B cells Mol Ther 2018 26 456 67 29273498 PMC5835153
  92. [104]Schumann K Lin S Boyer E Simeonov DR Subramaniam M Gate RE Generation of knock-in primary human T cells using Cas9 ribonucleoproteins Proc Natl Acad Sci U S A 2015 112 10437 42 26216948 PMC4547290
  93. [105]Kagoya Y Guo T Yeung B Saso K Anczurowski M Wang CH Genetic ablation of HLA class I, class II, and the T cell receptor enables allogeneic T cells to be used for adoptive T cell therapy Cancer Immunol Res 2020 8 926 36 32321775
  94. [106]Leonetti MD Sekine S Kamiyama D Weissman JS Huang B A scalable strategy for high-throughput GFP tagging of endogenous human proteins Proc Natl Acad Sci U S A 2016 113 E3501 E8 27274053 PMC4922190
  95. [107]Lee JK Jeong E Lee J Jung M Shin E Kim Yh Directed evolution of CRISPR-Cas9 to increase its specificity Nat Commun 2018 9 3048 30082838 PMC6078992
  96. [108]Nussing S House IG Kearney CJ Chen AXY Vervoort SJ Beavis PA Efficient CRISPR/Cas9 gene editing in uncultured naive mouse T cells for in vivo studies J Immunol 2020 204 2308 15 32152070
  97. [109]Kalebic N Taverna E Tavano S Wong FK Suchold D Winkler S CRISPR/Cas9-induced disruption of gene expression in mouse embryonic brain and single neural stem cells in vivo EMBO reports 2016 17 338 48 26758805 PMC4772980
  98. [110]Wu W Lu Z Li F Wang W Qian N Duan J Efficient in vivo gene editing using ribonucleoproteins in skin stem cells of recessive dystrophic epidermolysis bullosa mouse model Proc Natl Acad Sci U S A 2017 114 1660 5 28137859 PMC5321012
  99. [111]Modzelewski AJ Chen S Willis BJ Lloyd KCK Wood JA He L Efficient mouse genome engineering by CRISPR-EZ technology Nat Protoc 2018 13 1253 74 29748649 PMC6296855
  100. [112]Riggan L Hildreth AD Rolot M Wong YY Satyadi W Sun R CRISPR-Cas9 ribonucleoprotein-mediated genomic editing in mature primary innate immune cells Cell Rep 2020 31 107651 32433960 PMC7294876
  101. [114]Kim J Lee S Baek K Jin E Site-specific gene knock-out and on-site heterologous gene overexpression in Chlamydomonas reinhardtii via a CRISPR-Cas9-mediated knock-in method Front Plant Sci 2020 11 306 32265959 PMC7099044
  102. [115]Malvezzi AM Aricó M Souza-Melo N dos Santos GP Bittencourt-Cunha P Holetz FB GCN2-like kinase modulates stress granule formation during nutritional stress in Trypanosoma cruzi Front Cell Infect Microbiol 2020 10 149 32373547 PMC7176912
  103. [116]Canatella PJ Karr JF Petros JA Prausnitz MR Quantitative study of electroporation-mediated molecular uptake and cell viability Biophysical journal 2001 80 755 64 11159443 PMC1301274
  104. [117]Bak RO Dever DP Reinisch A Hernandez DC Majeti R Porteus MH Multiplexed genetic engineering of human hematopoietic stem and progenitor cells using CRISPR/Cas9 and AAV6 eLife 2017 6 e27873 28956530 PMC5656432
  105. [118]Yang R Lemaître V Huang C Haddadi A McNaughton R Espinosa HD Monoclonal cell line generation and CRISPR/Cas9 manipulation via single-cell electroporation Small 2018 14 e1702495 29430869 PMC6016377
  106. [119]Cao Y Ma E Cestellos-Blanco S Zhang B Qiu R Su Y Nontoxic nanopore electroporation for effective intracellular delivery of biological macromolecules Proc Natl Acad Sci U S A 2019 116 7899 904 30923112 PMC6475394
  107. [120]Nguyen DN Roth TL Li PJ Chen PA Apathy R Mamedov MR Polymer-stabilized Cas9 nanoparticles and modified repair templates increase genome editing efficiency Nat Biotechnol 2020 38 44 9 31819258 PMC6954310
  108. [121]Ma Y Han X Quintana Bustamante O Bessa de Castro R Zhang K Zhang P Highly efficient genome editing of human hematopoietic stem cells via a nano-silicon-blade delivery approach Integr Biol 2017 9 548 54 PMC5598083 28513735
  109. [122]Sharei A Zoldan J Adamo A Sim WY Cho N Jackson E A vector-free microfluidic platform for intracellular delivery Proc Natl Acad Sci U S A 2013 110 2082 7 23341631 PMC3568376
  110. [123]Fajrial AK He QQ Wirusanti NI Slansky JE Ding X A review of emerging physical transfection methods for CRISPR/Cas9-mediated gene editing Theranostics 2020 10 5532 49 32373229 PMC7196308
  111. [124]Han X Liu Z Ma Y Zhang K Qin L Cas9 ribonucleoprotein delivery via microfluidic cell-deformation chip for human T-cell genome editing and immunotherapy Adv Biosys 2017 1 1600007 32646183
  112. [125]Williams AR Bao S Miller DL Filtroporation: A simple, reliable technique for transfection and macromolecular loading of cells in suspension Biotechnol Bioeng 1999 65 341 6 10486133
  113. [126]Yen J Fiorino M Liu Y Paula S Clarkson S Quinn L TRIAMF: A New method for delivery of Cas9 ribonucleoprotein complex to human hematopoietic stem cells Sci Rep 2018 8 16304 30389991 PMC6214993
  114. [127]Chen Y Aslanoglou S Murayama T Gervinskas G Fitzgerald LI Sriram S Silicon-nanotube-mediated intracellular delivery enables ex vivo gene editing Adv Mater 2020 32 e2000036 32378244
  115. [128]Liu YC Vidali L Efficient polyethylene glycol (PEG) mediated transformation of the moss Physcomitrella patens J Vis Exp. 2011: e2560 PMC3169274 21540817
  116. [131]Koiso N Toda E Ichikawa M Kato N Okamoto T Development of gene expression system in egg cells and zygotes isolated from rice and maize Plant Direct 2017 1 e00010 31245659 PMC6508540
  117. [132]Osakabe Y Liang Z Ren C Nishitani C Osakabe K Wada M CRISPR-Cas9-mediated genome editing in apple and grapevine Nat Protoc 2018 13 2844 63 30390050
  118. [133]Woo JW Kim J Kwon SI Corvalán C Cho SW Kim H DNA-free genome editing in plants with preassembled CRISPR-Cas9 ribonucleoproteins Nat Biotechnol 2015 33 1162 4 26479191
  119. [135]Malnoy M Viola R Jung MH Koo OJ Kim S Kim JS DNA-free genetically edited grapevine and apple protoplast using CRISPR/Cas9 ribonucleoproteins Front Plant Sci 2016 7 1904 28066464 PMC5170842
  120. [136]Andersson M Turesson H Olsson N Falt AS Ohlsson P Gonzalez MN Genome editing in potato via CRISPR-Cas9 ribonucleoprotein delivery Physiol Plant 2018 164 378 84 29572864
  121. [137]Hooghvorst I Lopez-Cristoffanini C Nogues S Efficient knockout of phytoene desaturase gene using CRISPR/Cas9 in melon Sci Rep 2019 9 17077 31745156 PMC6863862
  122. [138]Leisen T Bietz F Werner J Wegner A Schaffrath U Scheuring D CRISPR/Cas with ribonucleoprotein complexes and transiently selected telomere vectors allows highly efficient marker-free and multiple genome editing in Botrytis cinerea PLoS Pathog 2020 16 e1008326 32804988 PMC7451986
  123. [139]Blechert O Mei H Zang X Zheng H Liang G Liu W Auxotrophic mutations of Trichophyton rubrum created by in vitro synthesized Cas9 ribonucleoprotein BMC Biotechnol 2020 20 6 31959181 PMC6971929
  124. [140]González MN Massa GA Andersson M Turesson H Olsson N Fält AS Reduced enzymatic browning in potato tubers by specific editing of a polyphenol oxidase gene via ribonucleoprotein complexes delivery of the CRISPR/Cas9 system Front Plant Sci 2020 10 1649 31998338 PMC6962139
  125. [142]Toda E Koiso N Takebayashi A Ichikawa M Kiba T Osakabe K An efficient DNA- and selectable-marker-free genome-editing system using zygotes in rice Nat Plants 2019 5 363 8 30911123
  126. [143]Choi JG Dang Y Abraham S Ma H Zhang J Guo H Lentivirus pre-packed with Cas9 protein for safer gene editing Gene Ther 2016 23 627 33 27052803
  127. [145]Lyu P Javidi-Parsijani P Atala A Lu B Delivering Cas9/sgRNA ribonucleoprotein (RNP) by lentiviral capsid-based bionanoparticles for efficient 'hit-and-run' genome editing Nucleic Acids Res 2019 47 e99 31299082 PMC6753487
  128. [146]Raposo G Stoorvogel W Extracellular vesicles: Exosomes, microvesicles, and friends J Cell Biol 2013 200 373 83 23420871 PMC3575529
  129. [147]El Andaloussi S Mäger I Breakefield XO Wood MJA Extracellular vesicles: Biology and emerging therapeutic opportunities Nat Rev Drug Discovery 2013 12 347 57 23584393
  130. [148]Zappulli V Pagh Friis K Fitzpatrick Z Maguire CA Breakefield XO Extracellular vesicles and intercellular communication within the nervous system J Clin Invest 2016 126 1198 207 27035811 PMC4811121
  131. [149]Wang Q Yu J Kadungure T Beyene J Zhang H Lu Q ARMMs as a versatile platform for intracellular delivery of macromolecules Nat Commun 2018 9 960 29511190 PMC5840177
  132. [150]Nabhan JF Hu R Oh RS Cohen SN Lu Q Formation and release of arrestin domain-containing protein 1-mediated microvesicles (ARMMs) at plasma membrane by recruitment of TSG101 protein Proc Natl Acad Sci U S A 2012 109 4146 51 22315426 PMC3306724
  133. [151]Ye Y Zhang X Xie F Xu B Xie P Yang T An engineered exosome for delivering sgRNA:Cas9 ribonucleoprotein complex and genome editing in recipient cells Biomater Sci 2020 8 2966 76 32342086
  134. [152]Mangeot PE Dollet S Girard M Ciancia C Joly S Peschanski M Protein transfer into human cells by VSV-G-induced nanovesicles Mol Ther 2011 19 1656 66 21750535 PMC3182355
  135. [154]Campbell LA Coke LM Richie CT Fortuno LV Park AY Harvey BK Gesicle-mediated delivery of CRISPR/Cas9 ribonucleoprotein complex for inactivating the HIV provirus Mol Ther 2019 27 151 63 30389355 PMC6318701
  136. [155]Gee P Lung MSY Okuzaki Y Sasakawa N Iguchi T Makita Y Extracellular nanovesicles for packaging of CRISPR-Cas9 protein and sgRNA to induce therapeutic exon skipping Nat Commun 2020 11 1334 32170079 PMC7070030
  137. [156]Li W Szoka FC Lipid-based nanoparticles for nucleic acid delivery Pharm Res 2007 24 438 49 17252188
  138. [157]Felgner PL Ringold GM Cationic liposome-mediated transfection Nature 1989 337 387 8 2463491
  139. [158]El Ouahabi A Thiry M Pector V Fuks R Ruysschaert JM Vandenbranden M The role of endosome destabilizing activity in the gene transfer process mediated by cationic lipids FEBS Letters 1997 414 187 92 9315683
  140. [159]Zhou X Huang L DNA transfection mediated by cationic liposomes containing lipopolylysine: characterization and mechanism of action Biochim Biophys Acta 1994 1189 195 203 8292625
  141. [160]Liang X Potter J Kumar S Zou Y Quintanilla R Sridharan M Rapid and highly efficient mammalian cell engineering via Cas9 protein transfection J Biotechnol 2015 208 44 53 26003884
  142. [161]Liu W Rudis MR Cheplick MH Millwood RJ Yang JP Ondzighi-Assoume CA Lipofection-mediated genome editing using DNA-free delivery of the Cas9/gRNA ribonucleoprotein into plant cells Plant Cell Rep 2020 39 245 57 31728703
  143. [162]Wang Y Wang B Xie H Ren Q Liu X Li F Efficient human genome editing using SaCas9 ribonucleoprotein complexes Biotechnol J 2019 14 e1800689 30927491
  144. [163]Kim K Park SW Kim JH Lee SH Kim D Koo T Genome surgery using Cas9 ribonucleoproteins for the treatment of age-related macular degeneration Genome Res 2017 27 419 26 28209587 PMC5340969
  145. [164]Aird EJ Lovendahl KN St Martin A, Harris RS, Gordon WR. Increasing Cas9-mediated homology-directed repair efficiency through covalent tethering of DNA repair template Commun Biol 2018 1 54 30271937 PMC6123678
  146. [165]Savic N Ringnalda FC Berk C Bargsten K Hall J Jinek M In vitro generation of CRISPR-Cas9 complexes with covalently bound repair templates for genome editing in mammalian cells Bio Protoc 2019 9 e3136 PMC6340478 30675496
  147. [166]Yu X Liang X Xie H Kumar S Ravinder N Potter J Improved delivery of Cas9 protein/gRNA complexes using lipofectamine CRISPRMAX Biotechnol Lett 2016 38 919 29 26892225 PMC4853464
  148. [167]Haapaniemi E Botla S Persson J Schmierer B Taipale J CRISPR-Cas9 genome editing induces a p53-mediated DNA damage response Nat Med 2018 24 927 30 29892067
  149. [168]de Almeida Monteiro Melo Ferraz M Nagashima JB Venzac B Le Gac S Songsasen N A dog oviduct-on-a-chip model of serous tubal intraepithelial carcinoma Sci Rep 2020 10 1575 32005926 PMC6994655
  150. [169]Chin JS Chooi WH Wang H Ong W Leong KW Chew SY Scaffold-mediated non-viral delivery platform for CRISPR/Cas9-based genome editing Acta Biomater 2019 90 60 70 30978509
  151. [170]Wang M Zuris JA Meng F Rees H Sun S Deng P Efficient delivery of genome-editing proteins using bioreducible lipid nanoparticles Proc Natl Acad Sci U S A 2016 113 2868 73 26929348 PMC4801296
  152. [171]Li Y Bolinger J Yu Y Glass Z Shi N Yang L Intracellular delivery and biodistribution study of CRISPR/Cas9 ribonucleoprotein loaded bioreducible lipidoid nanoparticles Biomater Sci 2019 7 596 606 30062347
  153. [172]Li Y Yang T Yu Y Shi N Yang L Glass Z Combinatorial library of chalcogen-containing lipidoids for intracellular delivery of genome-editing proteins Biomaterials 2018 178 652 62 29549971
  154. [173]Li Y Li AC Xu Q Intracellular delivery of His-tagged genome-editing proteins enabled by nitrilotriacetic acid-containing lipidoid nanoparticles Adv Healthc Mater 2019 8 1800996 PMC6474682 30565897
  155. [174]Cho EY Ryu JY Lee HAR Hong SH Park HS Hong KS Lecithin nano-liposomal particle as a CRISPR/Cas9 complex delivery system for treating type 2 diabetes J Nanobiotechnol 2019 17 19 PMC6350399 30696428
  156. [175]Kuhn J Lin Y Krhac Levacic A Al Danaf N Peng L Höhn M Delivery of Cas9/sgRNA ribonucleoprotein complexes via hydroxystearyl oligoamino amides Bioconjugate Chem 2020 31 729 42 31967454
  157. [176]Li J Røise JJ Zhang J Yang J Kerr DL Han H A novel fluorescent surfactant enhances the delivery of the Cas9 ribonucleoprotein and enables the identification of edited cells Chem Commun 2019 55 4562 5 PMC6503854 30931453
  158. [178]Yin J Wang Q Hou S Bao L Yao W Gao X Potent protein delivery into mammalian cells via a supercharged polypeptide J Am Chem Soc 2018 140 17234 40 30398334
  159. [179]Yin J Hou S Wang Q Bao L Liu D Yue Y Microenvironment-responsive delivery of the Cas9 RNA-guided endonuclease for efficient genome editing Bioconjug Chem 2019 30 898 906 30802405
  160. [180]Kim SM Shin SC Kim EE Kim SH Park K Oh SJ Simple in vivo gene editing via direct self-assembly of Cas9 ribonucleoprotein complexes for cancer treatment ACS Nano 2018 12 7750 60 30028587
  161. [181]Park YJ Chang L-C Liang JF Moon C Chung C-P Yang VC Nontoxic membrane translocation peptide from protamine, low molecular weight protamine (LMWP), for enhanced intracellular protein delivery: in vitro and in vivo study FASEB J 2005 19 1555 7 16033808
  162. [182]Ju A Lee SW Lee YE Han KC Kim JC Shin SC A carrier-free multiplexed gene editing system applicable for suspension cells Biomaterials 2019 217 119298 31280073
  163. [183]Shen Y Cohen JL Nicoloro SM Kelly M Yenilmez B Henriques F CRISPR-delivery particles targeting nuclear receptor-interacting protein 1 (Nrip1) in adipose cells to enhance energy expenditure J Bacteriol 2018 293 17291 305 PMC6222111 30190322
  164. [184]Del'Guidice T Lepetit-Stoffaes JP Bordeleau LJ Roberge J Théberge V Lauvaux C Membrane permeabilizing amphiphilic peptide delivers recombinant transcription factor and CRISPR-Cas9/Cpf1 ribonucleoproteins in hard-to-modify cells PLoS One 2018 13 e0195558 29617431 PMC5884575
  165. [185]Newcomb CJ Sur S Lee SS Yu JM Zhou Y Snead ML Supramolecular nanofibers enhance growth factor signaling by increasing lipid raft mobility Nano Lett 2016 16 3042 50 27070195 PMC4948975
  166. [186]Ji T Ding Y Zhao Y Wang J Qin H Liu X Peptide assembly integration of fibroblast-targeting and cell-penetration features for enhanced antitumor drug delivery Adv Mater 2015 27 1865 73 25651789
  167. [187]Rong G Wang C Chen L Yan Y Cheng Y Fluoroalkylation promotes cytosolic peptide delivery Sci Adv 2020 6 aaz1774 PMC7423368 32851155
  168. [188]Lostalé-Seijo I Louzao I Juanes M Montenegro J Peptide/Cas9 nanostructures for ribonucleoprotein cell membrane transport and gene edition Chem Sci 2017 8 7923 31 29619166 PMC5863697
  169. [189]Thach TT Bae DH Kim NH Kang ES Lee BS Han K Lipopeptide-based nanosome-mediated delivery of hyperaccurate CRISPR/Cas9 ribonucleoprotein for gene editing Small 2019 15 1903172 31588686
  170. [190]Chen JS Dagdas YS Kleinstiver BP Welch MM Sousa AA Harrington LB Enhanced proofreading governs CRISPR-Cas9 targeting accuracy Nature 2017 550 407 10 28931002 PMC5918688
  171. [191]Jain PK Lo JH Rananaware S Downing M Panda A Tai M Non-viral delivery of CRISPR/Cas9 complex using CRISPR-GPS nanocomplexes Nanoscale 2019 11 21317 23 31670340 PMC7709491
  172. [192]Wang M Liu H Li L Cheng Y A fluorinated dendrimer achieves excellent gene transfection efficacy at extremely low nitrogen to phosphorus ratios Nat Commun 2014 5 3053 24407172
  173. [194]Lv J Fan Q Wang H Cheng Y Polymers for cytosolic protein delivery Biomaterials 2019 218 119358 31349095
  174. [195]Sun M Wang K Oupicky D Advances in stimulus-responsive polymeric materials for systemic delivery of nucleic acids Adv Healthc Mater 2018 7 1701070 PMC5821579 29227047
  175. [197]Zhang Z Shen W Ling J Yan Y Hu J Cheng Y The fluorination effect of fluoroamphiphiles in cytosolic protein delivery Nat Commun 2018 9 1377 29636457 PMC5893556
  176. [199]Shen W Wang Q Shen Y Gao X Li L Yan Y Green tea catechin dramatically promotes RNAi mediated by low-molecular-weight polymers ACS Cent Sci 2018 4 1326 33 30410970 PMC6202644
  177. [200]Lv J Tan E Wang Y Fan Q Yu J Cheng Y Tailoring guanidyl-rich polymers for efficient cytosolic protein delivery J Control Release 2020 320 412 20 32014564
  178. [201]Yang J Zhang Q Chang H Cheng Y Surface-engineered dendrimers in gene delivery Chem Rev 2015 115 5274 300 25944558
  179. [203]Zhao L Wu Q Cheng Y Zhang J Wu J Xu T High-throughput screening of dendrimer-binding drugs J Am Chem Soc 2010 132 13182 4 20825185
  180. [204]Wang H Wang Y Wang Y Hu J Li T Liu H Self-assembled fluorodendrimers combine the features of lipid and polymeric vectors in gene delivery Angew Chem Int Ed 2015 54 11647 51 26260847
  181. [205]Ren L Lv J Wang H Cheng Y A coordinative dendrimer achieves excellent efficiency in cytosolic protein and peptide delivery Angew Chem Int Ed 2020 59 4711 9 31863674
  182. [206]Chang H Lv J Gao X Wang X Wang H Chen H Rational design of a polymer with robust efficacy for intracellular protein and peptide delivery Nano Lett 2017 17 1678 84 28206763
  183. [207]Lv S Wu Y Cai K He H Li Y Lan M High drug loading and sub-quantitative loading efficiency of polymeric micelles driven by donor-receptor coordination interactions J Am Chem Soc 2018 140 1235 8 29332390
  184. [209]Taharabaru T Yokoyama R Higashi T Mohammed AFA Inoue M Maeda Y Genome editing in a wide area of the brain using dendrimer-based ternary polyplexes of Cas9 ribonucleoprotein ACS Appl Mater Interfaces 2020 12 21386 97 32315156
  185. [210]Gao Y Huang J-Y O'Keeffe Ahern J Cutlar L Zhou D Lin F-H Highly branched poly(β-amino esters) for non-viral gene delivery: High transfection efficiency and low toxicity achieved by increasing molecular weight Biomacromolecules 2016 17 3640 7 27641634
  186. [211]Rui Y Wilson DR Sanders K Green JJ Reducible branched ester-amine quadpolymers (rBEAQs) codelivering plasmid DNA and RNA oligonucleotides enable CRISPR/Cas9 genome editing ACS Appl Mater Interfaces 2019 11 10472 80 30794383 PMC7309334
  187. [212]Rui Y Wilson DR Choi J Varanasi M Sanders K Karlsson J Carboxylated branched poly(β-amino ester) nanoparticles enable robust cytosolic protein delivery and CRISPR-Cas9 gene editing Sci Adv 2019 5 eaay3255 31840076 PMC6897553
  188. [214]Izaki S Kurinomaru T Handa K Kimoto T Shiraki K Stress tolerance of antibody-poly(amino acid) complexes for improving the stability of high concentration antibody formulations J Pharm Sci 2015 104 2457 63 26036204
  189. [216]Bagre AP Jain K Jain NK Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment Int J Pharm 2013 456 31 40 23994363
  190. [217]Schubert J Chanana M Coating matters: Review on colloidal stability of nanoparticles with biocompatible coatings in biological media, living cells and organisms Curr Med Chem 2018 25 4553 86 29852857 PMC7040520
  191. [218]Liu Q Cai J Zheng Y Tan Y Wang Y Zhang Z NanoRNP overcomes tumor heterogeneity in cancer treatment Nano Lett 2019 19 7662 72 31593471
  192. [219]Qiao J Sun W Lin S Jin R Ma L Liu Y Cytosolic delivery of CRISPR/Cas9 ribonucleoproteins for genome editing using chitosan-coated red fluorescent protein Chem Commun 2019 55 4707 10 30942216
  193. [220]Wan T Chen Y Pan Q Xu X Kang Y Gao X Genome editing of mutant KRAS through supramolecular polymer-mediated delivery of Cas9 ribonucleoprotein for colorectal cancer therapy J Controlled Release 2020 322 236 47 32169537
  194. [221]Chen G Ma B Wang Y Gong S A universal GSH-responsive nanoplatform for the delivery of DNA, mRNA, and Cas9/sgRNA ribonucleoprotein ACS Appl Mater Interfaces 2018 10 18515 23 29798662 PMC6141193
  195. [222]Wang Y Ma B Abdeen AA Chen G Xie R Saha K Versatile redox-responsive polyplexes for the delivery of plasmid DNA, messenger RNA, and CRISPR-Cas9 genome-editing machinery ACS Appl Mater Interfaces 2018 10 31915 27 30222305 PMC6530788
  196. [223]Chen G Abdeen AA Wang Y Shahi PK Robertson S Xie R A biodegradable nanocapsule delivers a Cas9 ribonucleoprotein complex for in vivo genome editing Nat Nanotechnol 2019 14 974 80 31501532 PMC6778035
  197. [224]Shah S Rangaraj N Laxmikeshav K Sampathi S "Nanogels as drug carriers - Introduction, chemical aspects, release mechanisms and potential applications" Int J Pharm 2020 581 119268 32240803
  198. [225]Yin Y Hu B Yuan X Cai L Gao H Yang Q Nanogel: A versatile nano-delivery system for biomedical applications Pharmaceutics 2020 12 290 PMC7151186 32210184
  199. [226]Ding F Huang X Gao X Xie M Pan G Li Q A non-cationic nucleic acid nanogel for the delivery of the CRISPR/Cas9 gene editing tool Nanoscale 2019 11 17211 5 31531437
  200. [227]Mout R Ray M Tay T Sasaki K Yesilbag Tonga G Rotello VM General strategy for direct cytosolic protein delivery via protein-nanoparticle co-engineering ACS Nano 2017 11 6416 21 28614657 PMC5766003

200 of 254 shown

Cited by

Sorted by citations

Authors
Zhang, S., Shen, J., Li, D., & Cheng, Y.
Affiliations
  • South China University of Technology (CN)
  • Taizhou Second People's Hospital (CN)
  • East China Normal University (CN)
Corresponding author
  • Li, Dali
  • Cheng, Yiyun
Venue
Theranostics
Published
2021
Volume
11
Issue
2
Pages
614-648
ISSN
1838-7640 (ISSN-L)
OpenAlex
W3097071384
Cited by
430
References
19
Citations by year
2026: 60 · 2025: 90 · 2024: 89 · 2023: 71 · 2022: 81 · 2021: 35 · 2020: 3
FWCI
15.41
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Theranostics (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
  • Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
Keywords
CRISPR/Cas9 genome editing, single guide RNA, stimuli-responsive carriers, targeted delivery, intracellular delivery, off-target effects, gene therapy
MeSH terms
Gene Editing, CRISPR-Associated Protein 9, RNA, Guide, CRISPR-Cas Systems, Animals, Humans, RNA, Guide, Kinetoplastida, Gene Transfer Techniques, CRISPR-Cas Systems

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review